14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jun 05, 2024 Sell 16 408 Vazzano Joseph Walter Common stock
Jun 05, 2024 Sell 38 621 Seshadri Vishwas Common Stock
Jun 05, 2024 Sell 10 951 O'malley Brendan M. Common stock
Jun 03, 2024 Sell 703 Seshadri Vishwas Common Stock
May 16, 2024 Buy 11 000 Alland Leila Common Stock
May 07, 2024 Buy 2 948 475 Adage Capital Management, L.p. Pre-funded Warrant (right to buy)
Apr 26, 2024 Buy 7 550 Charles Faith L. Common Stock
Apr 25, 2024 Buy 10 000 Seshadri Vishwas Common Stock
Apr 25, 2024 Buy 8 600 O'malley Brendan M. Common stock
Apr 25, 2024 Buy 5 608 Vazzano Joseph Walter Common stock
Mar 31, 2024 Sell 92 O'malley Brendan M. Common stock
Mar 15, 2024 Sell 703 Vazzano Joseph Walter Common stock
Mar 04, 2024 Sell 183 O'malley Brendan M. Common stock
Feb 06, 2024 Buy 20 000 Seshadri Vishwas Common Stock
Jan 17, 2024 Sell 7 084 Alvino Mark Common Stock
Oct 16, 2023 Sell 181 Seshadri Vishwas Common Stock
Sep 29, 2023 Sell 13 290 Seshadri Vishwas Common Stock
Sep 29, 2023 Sell 6 230 Vazzano Joseph Walter Common stock
Sep 29, 2023 Sell 6 557 O'malley Brendan M. Common stock
Sep 27, 2023 Sell 6 330 Silverstein Christine Berni Common Stock
Sep 27, 2023 Sell 6 316 Alvino Mark Common Stock
Sep 27, 2023 Sell 8 330 Charles Faith L. Common Stock
Sep 27, 2023 Sell 7 246 Alland Leila Common Stock
Sep 27, 2023 Sell 5 508 Amoroso Michael Common Stock
Sep 27, 2023 Buy 20 000 Seshadri Vishwas Common Stock
Sep 21, 2023 Sell 563 O'malley Brendan M. Common stock
Sep 20, 2023 Sell 327 Amoroso Michael Common Stock
Sep 19, 2023 Buy 2 986 Vazzano Joseph Walter Common stock
Sep 19, 2023 Buy 14 Vazzano Joseph Walter Common stock
Sep 18, 2023 Buy 3 000 O'malley Brendan M. Common stock
Jul 24, 2023 Sell 1 187 Vazzano Joseph Walter Common stock
Jul 03, 2023 Buy 0 Adage Capital Partners Gp, L.l.c. Common Stock, $0.01 par value ("Common Stock")
Jun 20, 2023 Sell 338 Amoroso Michael Common Stock
Jun 14, 2023 Buy 58 689 Alvino Mark Common Stock
Jun 14, 2023 Buy 58 689 Amoroso Michael Common Stock
Jun 14, 2023 Buy 58 689 Charles Faith L. Common Stock
Jun 14, 2023 Buy 58 689 Silverstein Christine Berni Common Stock
Jun 14, 2023 Buy 58 689 Wuchterl Donald A. Common Stock
Jun 14, 2023 Buy 58 689 Alland Leila Common Stock
Jun 05, 2023 Buy 336 826 Seshadri Vishwas Common Stock
Jun 05, 2023 Buy 141 908 Vazzano Joseph Walter Common stock
Jun 05, 2023 Buy 90 902 O'malley Brendan M. Common stock
Jun 02, 2023 Sell 827 Seshadri Vishwas Common Stock
Apr 25, 2023 Sell 887 Alvino Mark Common Stock
Apr 03, 2023 Sell 104 O'malley Brendan M. Common stock
Mar 20, 2023 Sell 268 Amoroso Michael Common Stock
Mar 15, 2023 Sell 792 Vazzano Joseph Walter Common stock
Mar 03, 2023 Sell 1 002 Amoroso Michael Common Stock
Mar 03, 2023 Sell 207 O'malley Brendan M. Common stock
Dec 09, 2022 Buy 5 869 O'malley Brendan M. Common stock
Nov 18, 2022 Buy 2 500 Vazzano Joseph Walter Common stock
Nov 18, 2022 Buy 7 500 O'malley Brendan M. Common stock
Nov 07, 2022 Buy 760 870 Adage Capital Partners Gp, L.l.c. Warrants (right to buy)
Oct 17, 2022 Sell 207 Seshadri Vishwas Common Stock
Sep 28, 2022 Buy 155 200 Seshadri Vishwas Common Stock
Sep 28, 2022 Buy 72 750 O'malley Brendan M. Common stock
Sep 28, 2022 Buy 72 750 Vazzano Joseph Walter Common stock
Sep 26, 2022 Buy 13 400 Amoroso Michael Common Stock
Sep 26, 2022 Buy 13 400 Mann Paul Elliot Common Stock
Jul 21, 2022 Buy 12 000 Vazzano Joseph Walter Common stock
Jun 15, 2022 Sell 20 000 Alvino Mark Common Stock
Jun 06, 2022 Sell 35 000 Alvino Mark Common Stock
Jun 01, 2022 Sell 81 525 Seshadri Vishwas Common Stock
Mar 14, 2022 Buy 200 000 Vazzano Joseph Walter Common stock
Mar 14, 2022 Buy 0 Vazzano Joseph Walter Common stock
Dec 06, 2021 Sell 8 880 O'malley Brendan M. Common stock
Nov 05, 2021 Sell 8 880 O'malley Brendan M. Common stock
Oct 15, 2021 Buy 50 000 Seshadri Vishwas Common stock
Oct 15, 2021 Buy 300 000 Seshadri Vishwas Stock Option (right to buy)
Oct 11, 2021 Sell 25 734 O'malley Brendan M. Common stock
Oct 08, 2021 Sell 22 763 O'malley Brendan M. Common stock
Oct 08, 2021 Sell 29 122 Carr Edward Common stock
Oct 07, 2021 Sell 25 000 Wider Todd Common Stock
Oct 05, 2021 Sell 2 447 O'malley Brendan M. Common stock
Sep 30, 2021 Sell 45 409 Amoroso Michael Common stock
Sep 20, 2021 Buy 136 000 O'malley Brendan M. Common stock
Sep 20, 2021 Buy 272 000 O'malley Brendan M. Stock Option (right to buy)
Sep 20, 2021 Buy 0 O'malley Brendan M. Common stock
Sep 20, 2021 Buy 50 000 O'malley Brendan M. Stock Option (right to buy)
Sep 20, 2021 Buy 100 000 O'malley Brendan M. Stock Option (right to buy)
Aug 10, 2021 Buy 476 000 Carr Edward Stock Option (right to buy)
Aug 10, 2021 Buy 238 000 Carr Edward Common stock
Jun 01, 2021 Buy 400 000 Seshadri Vishwas Stock Option (right to buy)
Jun 01, 2021 Buy 100 000 Seshadri Vishwas Common stock
Jun 01, 2021 Buy 200 000 Seshadri Vishwas Common stock
Jun 01, 2021 Buy 0 Seshadri Vishwas
May 25, 2021 Buy 98 168 Wuchterl Donald A. Stock Option (right to buy)
May 25, 2021 Buy 77 181 Wuchterl Donald A. Common Stock
May 25, 2021 Buy 49 084 Mann Paul Elliot Stock Option (right to buy)
May 25, 2021 Buy 38 590 Mann Paul Elliot Common Stock
May 25, 2021 Buy 38 590 Wider Todd Common Stock
May 25, 2021 Buy 49 084 Wider Todd Stock Option (right to buy)
May 25, 2021 Buy 98 168 Charles Faith L. Stock Option (right to buy)
May 25, 2021 Buy 77 181 Charles Faith L. Common Stock
May 25, 2021 Buy 38 590 Silverstein Christine Berni Common Stock
May 25, 2021 Buy 49 084 Silverstein Christine Berni Stock Option (right to buy)
May 25, 2021 Buy 98 168 Alvino Mark Stock Option (right to buy)
May 25, 2021 Buy 77 181 Alvino Mark Common Stock
May 25, 2021 Buy 38 590 Rouhandeh Steven H Common Stock
May 25, 2021 Buy 49 084 Rouhandeh Steven H Stock Option (right to buy)
INSIDER POWER
92.225
Last 100 transactions
Buy: 8 473 985 | Sell: 446 202 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 92.225.

In total, the insiders bought 8 473 985 and sold 446 202 ABEO shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT